News

Platinum is a pivotal, randomised, controlled clinical trial program designed to support Administration and Japanese Ministry of Health, Labor and Welfare approval of the Promus Element Stent. The

Vitride reducing agent has multiple applications in pharmaceutical, flavor and fragrance as well as agrochemical manufacture. The increased manufacturing capacity is scheduled to be operational in June 2010

The data were presented at the American College of Cardiology (ACC) meeting in Atlanta, Georgia. The analysis included 1261 patients who were on study medication up to seven

AssistMed’s Patient Adherence Solutions include Clinication, a web-based patient/provider adherence management system and CellPly, a device-independent mobile phone solution which follows the patient wherever they may be. The

The tool was developed by Harvard Catalyst, The Harvard Clinical and Translational Science Center, and was officially released to the open source community by Harvard University. Profiles Research

NextDocs is expected to provide software licenses and solutions to customers and Hitachi will provide supporting services including business consulting, system integration, training, operation and validation support for

LLS has committed substantial, multi-year funding to support this collaboration, which is an expansion of partnership between both the companies in July 2009, as part of its Therapy

Zanidip (lercanidipine) belongs to a group of medicines called calcium channel blockers (CCB’s) which is widely prescribed for the treatment of hypertension. Zanidip (lercanidipine) is a dihydropyridine (DHP)

West Coast Clinical Trials said that the new unit is expected to enable it to house additional clinical research participants and expand its base of operations. Tom Pillsworth,